Vaccinex Reports Phase Ib KEYNOTE B84 Combination Study of Keytruda® and Pepinemab in Patients with Advanced, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Passes Planned Interim Safety Analysis

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach